Bayer Sells $3. 4 Billion Contraceptives Stake to Apollo Bayer's decision to sell its contraceptives stake for a staggering $3.
4 billion has sent shockwaves through the pharmaceutical industry, marking a significant shift in the company's strategic priorities with far reaching implications for the global contraceptive market.
What's Behind Bayer's $3. 4 Billion Contraceptives Stake Sell? The sale of Bayer's contraceptives stake to Apollo Global Management, a New York based private equity firm, is a pragmatic move by the German pharma giant.